We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+11.68%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$19.1B
AUM Growth
+$1.76B
Cap. Flow
+$154M
Cap. Flow %
0.81%
Top 10 Hldgs %
32.12%
Holding
703
New
28
Increased
257
Reduced
281
Closed
39

Top Buys

Rank Stock Value
1
NU icon
Nu Holdings
NU
+$60.7M
2
JNJ icon
Johnson & Johnson
JNJ
+$58.3M
3
SCHW
Charles Schwab
SCHW
+$54M
4
ABBV icon
AbbVie
ABBV
+$52.9M
5
PANW icon
Palo Alto Networks
PANW
+$42.9M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$92.7M
2
EMR icon
Emerson Electric
EMR
+$57.2M
3
MELI icon
Mercado Libre
MELI
+$48.9M
4
AVGO icon
Broadcom
AVGO
+$38.9M
5
MU icon
Micron Technology
MU
+$37.7M

Sector Composition

Rank Sector Weight
1 Technology 36.63%
2 Healthcare 23.08%
3 Financials 11.48%
4 Consumer Discretionary 7.78%
5 Communication Services 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FUTU icon
126
Futu Holdings
FUTU
$14.3B
$32.3M 0.17%
185,747
+115,690
+165% +$19.2M
ALL icon
127
Allstate
ALL
$70.1B
$32M 0.17%
149,091
-15,222
-9% -$3.07M
VNO icon
128
Vornado Realty Trust
VNO
$7.54B
$31.8M 0.17%
785,413
+498,564
+174% +$19.4M
AMP icon
129
Ameriprise Financial
AMP
$48.3B
$31.4M 0.16%
63,839
+29,116
+84% +$14.9M
CRNX icon
130
Crinetics Pharmaceuticals
CRNX
$8.88B
$31M 0.16%
745,094
+51,225
+7% +$1.64M
CAH icon
131
Cardinal Health
CAH
$54.5B
$30.8M 0.16%
196,163
+19,155
+11% +$2.96M
CCK icon
132
Crown Holdings
CCK
$13.2B
$30.7M 0.16%
317,563
+144,935
+84% +$14.5M
CMCSA icon
133
Comcast
CMCSA
$85.8B
$29.9M 0.16%
952,154
+32,262
+4% +$1.08M
MIRM icon
134
Mirum Pharmaceuticals
MIRM
$6.84B
$29.5M 0.15%
403,026
+30,021
+8% +$1.91M
BMRN icon
135
BioMarin Pharmaceuticals
BMRN
$12B
$29.4M 0.15%
542,764
-6,891
-1% -$394K
GE icon
136
GE Aerospace
GE
$377B
$29.1M 0.15%
96,821
+9,752
+11% +$2.67M
EXEL icon
137
Exelixis
EXEL
$14.2B
$28.7M 0.15%
696,104
+108,367
+18% +$4.36M
NUVL
138
DELISTED
Nuvalent
NUVL
$28.5M 0.15%
329,721
+28,462
+9% +$2.25M
IDYA icon
139
IDEAYA Biosciences
IDYA
$3.48B
$27.6M 0.14%
1,012,967
+98,567
+11% +$2.38M
MCD icon
140
McDonald's
MCD
$194B
$27.3M 0.14%
89,886
+3,571
+4% +$1.09M
KEYS icon
141
Keysight
KEYS
$52.2B
$27.3M 0.14%
155,945
-1,958
-1% -$326K
OLED icon
142
Universal Display
OLED
$3.85B
$27.1M 0.14%
189,015
-6,291
-3% -$915K
HOLX
143
DELISTED
Hologic
HOLX
$26.9M 0.14%
399,277
CL icon
144
Colgate-Palmolive
CL
$74.2B
$26.9M 0.14%
335,917
+3,908
+1% +$333K
IAG icon
145
IAMGOLD
IAG
$8.24B
$26.6M 0.14%
2,060,000
-437,000
-18% -$3.83M
JBL icon
146
Jabil
JBL
$31.7B
$26.5M 0.14%
121,885
+76,523
+169% +$16.7M
FTNT icon
147
Fortinet
FTNT
$110B
$26.1M 0.14%
310,163
+607
+0.2% +$54.2K
GL icon
148
Globe Life
GL
$13.9B
$25.9M 0.14%
181,435
+36,646
+25% +$4.97M
TPR icon
149
Tapestry
TPR
$30.5B
$25.9M 0.14%
228,712
-32,122
-12% -$3.36M
VLTO icon
150
Veralto
VLTO
$24.2B
$25.8M 0.14%
242,190
-494
-0.2% -$52.1K

Similar funds

Candriam SCA's Q3 2025 Portfolio in Review

As of Q3 2025, Candriam SCA held 703 positions worth $19.1B, up 10% from $17.3B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q3 2025 filing shows 28 new, 257 increased, 281 reduced and 39 closed positions. Its largest new stake was Banco Macro: 322,600 shares worth $13.6M. The largest sale was NVIDIA, an estimated $92.7M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2025 buy was Banco Macro: 322,600 shares worth $13.6M.
  • Candriam SCA added most to Nu Holdings in Q3 2025, an estimated $60.7M increase.
  • Candriam SCA's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $92.7M.
  • Candriam SCA fully exited Verona Pharma in Q3 2025, selling an estimated $20.5M.
  • Candriam SCA's ten largest holdings make up 32% of its $19.1B portfolio in Q3 2025.
  • Candriam SCA opened 28 new positions and closed 39 in Q3 2025.
  • Candriam SCA's portfolio value rose 10% quarter-over-quarter to $19.1B.

Based on Candriam SCA's 13F filing for Q3 2025, filed 6 Nov 2025.